SARS-CoV-2 cellular infection is
mediated by the heavily glycosylated
spike protein. Recombinant versions of the spike protein and the receptor-binding
domain (RBD) are necessary for seropositivity assays and can potentially
serve as vaccines against viral infection. RBD plays key roles in
the spike protein’s structure and function, and thus, comprehensive
characterization of recombinant RBD is critically important for biopharmaceutical
applications. Liquid chromatography coupled to mass spectrometry has
been widely used to characterize post-translational modifications
in proteins, including glycosylation. Most studies of RBDs were performed
at the proteolytic peptide (bottom-up proteomics) or released glycan
level because of the technical challenges in resolving highly heterogeneous
glycans at the intact protein level. Herein, we evaluated several
online separation techniques: (1) C2 reverse-phase liquid chromatography
(RPLC), (2) capillary zone electrophoresis (CZE), and (3) acrylamide-based
monolithic hydrophilic interaction chromatography (HILIC) to separate
intact recombinant RBDs with varying combinations of glycosylations
(glycoforms) for top-down mass spectrometry (MS). Within the conditions
we explored, the HILIC method was superior to RPLC and CZE at separating
RBD glycoforms, which differ significantly in neutral glycan groups.
In addition, our top-down analysis readily captured unexpected modifications
(e.g., cysteinylation and N-terminal sequence variation) and low abundance,
heavily glycosylated proteoforms that may be missed by using glycopeptide
data alone. The HILIC top-down MS platform holds great potential in
resolving heterogeneous glycoproteins for facile comparison of biosimilars
in quality control applications.